We have congregated information concerning stocks with the highest payout ratio at the moment. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.
1. Pangaea Logistics Solutions Ltd.
525% Payout Ratio
Pangaea Logistics Solutions, Ltd., together with its subsidiaries, provides seaborne dry bulk logistics and transportation services to industrial customers worldwide.
As maintained by Morningstar, Inc., the next dividend pay date is on Nov 19, 2019, the estimated forward annual dividend rate is a negative 0 and the estimated forward annual dividend yield is a negative0%.
Pangaea Logistics Solutions Ltd. sales growth this year is anticipated to be negative 10.7% and 4.5% for next year.
Year-on-year quarterly revenue growth declined by 12.7%, now sitting on 400.52M for the twelve trailing months.
Pangaea Logistics Solutions Ltd.'s sales growth is a negative 24.9% for the present quarter and negative 0% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 0% and 56.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.76%.
Pangaea Logistics Solutions Ltd.'s Stock Top and Bottom Yearly Value
Pangaea Logistics Solutions Ltd.'s stock is valued at $2.55 at 08:58 EST, way below its 52-week high of $3.51 and way higher than its 52-week low of $1.60.
Pangaea Logistics Solutions Ltd.'s Moving Average
Pangaea Logistics Solutions Ltd.'s value is way below its 50-day moving average of $2.84 and higher than its 200-day moving average of $2.47.
2. Alexandria Real Estate Equities, Inc.
95.43% Payout Ratio
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500 urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $27.
As maintained by Morningstar, Inc., the next dividend pay date is on Dec 29, 2020, the estimated forward annual dividend rate is 4.36 and the estimated forward annual dividend yield is 2.55%.
Alexandria Real Estate Equities, Inc. sales growth this year is anticipated to be 26.5% and 3.6% for next year.
Year-on-year quarterly revenue growth grew by 39.5%, now sitting on 1.85B for the twelve trailing months.
Alexandria Real Estate Equities, Inc.'s sales growth for the next quarter is 8.2%. The company's growth estimates for the ongoing quarter and the next is a negative 62.6% and 342.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.5%.
Alexandria Real Estate Equities, Inc.'s Stock Top and Bottom Yearly Value
Alexandria Real Estate Equities, Inc.'s stock is valued at $171.26 at 08:58 EST, under its 52-week high of $177.70 and way above its 52-week low of $109.22.
Alexandria Real Estate Equities, Inc.'s Moving Average
Alexandria Real Estate Equities, Inc.'s value is above its 50-day moving average of $161.71 and above its 200-day moving average of $164.07.
3. W.P. Carey Inc. REIT
160.77% Payout Ratio
As maintained by Morningstar, Inc., the next dividend pay date is on Sep 28, 2020, the estimated forward annual dividend rate is 4.18 and the estimated forward annual dividend yield is 6.03%.
W.P. Carey Inc. REIT sales growth this year is expected to be negative 0.5% and 4.8% for next year.
Year-on-year quarterly revenue growth declined by 1.3%, now sitting on 1.19B for the twelve trailing months.
W.P. Carey Inc. REIT's sales growth for the next quarter is 3%. The company's growth estimates for the current quarter and the next is a negative 40% and 13.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.66%.
W.P. Carey Inc. REIT's Stock Top and Bottom Yearly Value
W.P. Carey Inc. REIT's stock is valued at $69.44 at 08:58 EST, way under its 52-week high of $88.99 and way higher than its 52-week low of $38.62.
W.P. Carey Inc. REIT's Moving Average
W.P. Carey Inc. REIT's value is above its 50-day moving average of $67.28 and above its 200-day moving average of $67.83.
4. B&G Foods, Inc.
94.06% Payout Ratio
B&G Foods, Inc. manufactures, sells, and distributes a portfolio of shelf-stable and frozen foods, and household products in the United States, Canada, and Puerto Rico.
As maintained by Morningstar, Inc., the next dividend pay date is on Dec 29, 2020, the estimated forward annual dividend rate is 1.9 and the estimated forward annual dividend yield is 6.6%.
B&G Foods, Inc. sales growth this year is anticipated to be 19.6% and a negative 0.8% for next year.
Year-on-year quarterly revenue growth grew by 22%, now sitting on 1.93B for the twelve trailing months.
B&G Foods, Inc.'s sales growth for the next quarter is 15.1%. The company's growth estimates for the present quarter and the next is 57.1% and 28.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.42%.
B&G Foods, Inc.'s Stock Top and Bottom Yearly Value
B&G Foods, Inc. B&G Foods, Inc.'s stock is valued at $28.68 at 08:58 EST, way below its 52-week high of $31.93 and way above its 52-week low of $10.39.
B&G Foods, Inc.'s Moving Average
B&G Foods, Inc. B&G Foods, Inc.'s worth is higher than its 50-day moving average of $27.42 and higher than its 200-day moving average of $27.18.
Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
